News
Product Receives Approval in Israel
Medical Device Approval & Free Sale Certificate granted by Israeli Ministry of Health for Ocular Discovery’s Dipyridamole patented dose range eye drop formulation
Read More$4.4 Million Seed Funding Round Complete
Ocular Discovery secures $4.4 Million in seed funding led by Norma Investments
Read MorePatent Granted in Israel
Patent allowance granted in Israel for the indication of Lacrimal and Anterior Eye Segment Disorders
Read MoreFirst U.S. Patent Granted
Ocular Discovery receives its first patent allowance in the United States for the indications of Lacrimal System Disorders, Dry Eye and Sjogren’s syndrome in the eye
Read More